PRA International to Exhibit at ESC's Annual Conference

Opportunity to Meet with PRA Experts

RALEIGH, North Carolina, August 23, 2010 - PRA International, a leading Clinical Research Organization, will exhibit
our cardiology expertise and experience at the European Society of
Cardiology's (ESC) annual conference in Stockholm, Sweden from 28 August to 1
September 2010.

At PRA booth C18:62, attendees can schedule meetings with our leading
expert in cardiovascular (CV) disease, Dr. Michael Kirchengast, Vice
President and Head of Scientific Affairs at PRA, to learn how PRA can support
drug development projects.

In addition to his ESC attendance, Dr. Kirchengast is also hosting a CV
audio conference on 24 August 2010 at 11:30 am (EDT). Those wishing to attend
this session can learn key concepts and explore new strategies for preventing
some of the expensive failures that pharmaceutical companies experience
during late-stage development.

Dr. Kirchengast has 30 years of experience in CV research and
development, including interactions with multiple authorities. His wide range
of development experience encompasses antiarrhythmics, antithrombotics,
antihypertensives, antihyperlipidemics, heart failure therapeutics, and
vascularly active and cardioprotective drugs.

Additional PRA representatives, including Dr. Margit Banagl, Executive
Director of Medical Affairs, will be at ESC to provide information on the
full breadth of PRA's services.

For more information about our ESC exhibit and Dr. Kirchengast's audio
conference, navigate to www.praintl.com and click on "Events." To
register for the audio conference, email endpoints@praintl.com.

About PRA International

PRA International conducts clinical trials in more than 85 countries
across 6 continents and provides services through all phases of clinical
development. PRA performs studies in all therapeutic areas, with
specialization in Oncology/Hematology, Neurosciences, Respiratory/Allergy,
Cardiovascular and Infectious Diseases. In the last five years, PRA has
supported over 2,700 clinical trials through its 37 global offices.

PRA's therapeutic expertise, global reach and project experience,
combined with extensive local knowledge and our differentiating PERSONAL
ELEMENT enable our project teams to deliver consistent and on-time
performance for our clients. This unique PRA philosophy - THE PERSONAL
ELEMENT - recognizes that true client service comes only from trained,
empowered and dedicated employees who are encouraged to use innovation and
their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit
www.PRAinternational.com, email Endpoints@PRAintl.com or call our
Global Headquarters at +1-919-786-8200.

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924